Evidence map›Paper›PMID 27867275›Full record

ArticlePharmacognosy magazine

Improved Oral Bioavailability of Total Flavonoids of

Cheng Zeng, Wen Jiang, Meie Tan, Jianguo Xing, Chenghui He

Open access · greenAbstract read
In one paragraph

Article in Pharmacognosy magazine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. A Comprehensive Review of the Phenolic Compounds inMolecules (Basel, Switzerland) · 2025
    Review
  2. Kinetic Study ofPolymers · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cheng ZengXinjiang Institute of Materia Medica, Urumqi, P. R. China; Institute of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi, P. R. China.
Wen JiangDepartment of Pharmacy, The Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, P. R. China.
Meie TanXinjiang Institute of Materia Medica, Urumqi, P. R. China.
Jianguo XingXinjiang Institute of Materia Medica, Urumqi, P. R. China.
Chenghui HeXinjiang Institute of Materia Medica, Urumqi, P. R. China.
Xinjiang Institute of Materia Medica · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectivesTo prepare composite phospholipid liposome (CPL) encapsulatetotal flavonoids extract from MATERIAL AND

methodsThe TFDMCPL was prepared by the method of ammonium sulfate transmembrane gradients. The CPL and TFDM were separated by Sephadex-G50 chromatography. The concentration of TFDM in the CPL was detected by HPLC, then the entrapment efficiency (EE) was evaluated. And the shape, particle size, zeta potential, drug release

resultsThe EE of TFDM was 84.17±2.2%, mean size of TFDMCPL was 136.2±3.7nm, polymey disperse index (PDI) was 0.158±0.015 and zeta potential was -19.8±1.2mV. TFDM-CPLwere found to enhance the release of drugs more effectively than TFDM based on the

conclusionThe method of ammonium sulfate transmembrane gradients is suitable for preparingTFDM-CPL. And TFDM-CPL have potential to be used to improve the bioavailability of poorly soluble drugs after oral administration. SUMMARY: For the first time, composite phospholipid liposomes (CPL) containing total flavonoids of Dracocephalum moldavica (TFDM) were developed by method of ammonium sulfate transmembrane gradients.The TFDM-CPL was a significant improvement in bioavailability compared to the TFDM-solution, with a 10-fold increase in relative bioavailability

Indexed as

composite phospholipid liposomeentrapment efficiencyin vitro drug releasePharmacokineticsTotal flavonoids extract from Dracocephalum moldavica

Identifiers

PMID27867275
PMCPMC5096279
OpenAlexW2555300885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.